Feelings and Fears in Adults With and Without Cystic Fibrosis
Cystic Fibrosis results in progressive chronic lung disease and multiple comorbidities. In 2009–2010 the H1N1 influenza pandemic resulted in significant morbidity in most people with Cystic Fibrosis who contracted the infection. Many countries categorised people with Cystic Fibrosis as highly vulnerable to COVID-19 and advised shielding to try to minimise the risk of people with CF contracting the virus. The impact of acute infection with COVID-19 in people with Cystic Fibrosis was not known.1
In this webinar Prof Castellani investigates the effects of the pandemic on both Cystic Fibrosis patients and the general population. Detail is given on studies that look into the mental health of patients during the COVID-19 lockdowns, their emotional well-being and also the anxieties experienced amongst children with Cystic Fibrosis and their carers.
The development of an expanded questionnaire is also discussed which looked at demographic data, health conditions during lockdown, emotional symptoms and also some Cystic Fibrosis specific questions. The data pooled from this questionnaire is discussed in relation to a wider survey of similar questions posed to the general Italian population.
1. Cosgriff R. A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis. J Cyst Fibros. 2020; 19(3): 355–358.
We hope that you found the content valuable. To ensure that we continue to provide topics and content of interest, we would very much value your feedback by completing a short questionnaire.
Professor Carlo Castellani
Prof Castellani is the deputy editor for the Journal of Cystic Fibrosis and is the current President of the Italian Cystic Fibrosis Society. He has also served on a number of committees including the board of the Italian Cystic Fibrosis Working Group and the Commission on Patterns of Genetic Analysis for Cystic Fibrosis. His main clinical and research interests lie in CF epidemiology, genotype/phenotype correlation, CF diagnosis, CFTR-related disorders, neonatal screening and CF adult care.